bridgebio pharma announces opportunity for accelerated approval pathway in limb-girdle muscular dystrophy type 2i (lgmd2i/r9)

Supporting Research Toward a Cure for Limb Girdle Muscular Dystrophy, Type 2i
Supporting Research Toward a Cure for Limb Girdle Muscular Dystrophy, Type 2i